Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

• Yan-Ming Zeng,
• Xiao-Lei Xu,
• Xiao-Qing He,
• Sheng-Quan Tang,
• Yao Li,
• Yin-Qiu Huang,
• Vijay Harypursat,
• Yao-Kai Chen,
• Peng Lyu

Affiliations

Yan-Ming Zeng

Xiao-Lei Xu

Xiao-Qing He

Sheng-Quan Tang

Yao Li

Yin-Qiu Huang

Vijay Harypursat

Yao-Kai Chen

Peng Lyu